The PREDICT® platform is dedicated to conventional pharmacology. It centralizes the whole range of skills, assays and databases to conduct complete pharmacological characterization of anti-cancer drugs and to provide proof of concept of the efficacy of your lead compounds.
A large panel of techniques are routinely used, such as preclinical
automated in vitro cytotoxicity screening, cytometry, molecular biology,
angiogenesis assays, drug formulation, SPF animal care, histopathology
and immunohistochemistry, long term in
vivo infusion, microsurgery, analytical
chemistry for PK, biodistribution and metabolism of compounds, imaging
of drug efficacy, dedicated software for in vivo study
management (Vivo manager®), ...
All our assays are standardized with reference drugs and positive controls for quality controls.